Search by Drug Name or NDC
NDC 00173-0547-00 MEPRON 750 mg/5mL Details
MEPRON 750 mg/5mL
MEPRON is a ORAL SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by GlaxoSmithKline LLC. The primary component is ATOVAQUONE.
MedlinePlus Drug Summary
Atovaquone is used to treat Pneumocystis jiroveci [Pneumocystis carinii] pneumonia (PCP; type of pneumonia most likely to affect people with human immunodeficiency virus [HIV]) in teenagers and adults. Atovaquone is also used to prevent PCP in teenagers and adults who cannot take another medication used for prevention. Atovaquone is in a class of medications called antiprotozoal agents. It works by stopping the growth of certain types of protozoa that can cause pneumonia.
Related Packages: 00173-0547-00Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Atovaquone
Product Information
NDC | 00173-0547 |
---|---|
Product ID | 0173-0547_a88a003d-2672-4782-8d24-62b2bf6e64ba |
Associated GPIs | 16400020001820 |
GCN Sequence Number | 023399 |
GCN Sequence Number Description | atovaquone ORAL SUSP 750 MG/5ML ORAL |
HIC3 | W4K |
HIC3 Description | ANTIPROTOZOAL DRUGS,MISCELLANEOUS |
GCN | 34490 |
HICL Sequence Number | 006619 |
HICL Sequence Number Description | ATOVAQUONE |
Brand/Generic | Brand |
Proprietary Name | MEPRON |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | atovaquone |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | SUSPENSION |
Route | ORAL |
Active Ingredient Strength | 750 |
Active Ingredient Units | mg/5mL |
Substance Name | ATOVAQUONE |
Labeler Name | GlaxoSmithKline LLC |
Pharmaceutical Class | Antimalarial [EPC], Antiprotozoal [EPC] |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA020500 |
Listing Certified Through | 2024-12-31 |
Package
NDC 00173-0547-00 (00173054700)
NDC Package Code | 0173-0547-00 |
---|---|
Billing NDC | 00173054700 |
Package | 42 POUCH in 1 DOSE PACK (0173-0547-00) / 5 mL in 1 POUCH |
Marketing Start Date | 1998-09-18 |
NDC Exclude Flag | N |
Pricing Information | N/A |